Nitrogen chemistry and lung physiology

Annual Review of Physiology

Volumn 77, Issue , 2015, Pages 431-452

  Marozkina, Nadzeya V ^a   Gaston, Benjamin ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Asthma; Cystic fibrosis; Denitrification; Lung ecology; Nitric oxide; Pulmonary hypertension; S nitrosylation

Indexed keywords

AMINE; AMINO ACID; AMMONIA; ANION; FREE RADICAL; GUANYLATE CYCLASE; HEMOGLOBIN; HYDROXYLAMINE; NITRIC OXIDE; NITROGEN; NITROGEN OXIDE; NITROUS OXIDE; OXYGEN; S NITROSOTHIOL; TERTIARY AMINE;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY; ARTICLE; ASTHMA; BIOCHEMISTRY; BIOLOGICAL ACTIVITY; CHEMICAL BOND; CHEMICAL REACTION; CILIARY DYSKINESIA; CYSTIC FIBROSIS; DENITRIFICATION; DENITROSYLATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ERYTHROCYTE; EUKARYOTIC CELL; HUMAN; LUNG CANCER; LUNG DISEASE; LUNG FUNCTION; LUNG INJURY; MEMBRANE BIOLOGY; NITROGEN METABOLISM; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE; ANIMAL; DISEASE MODEL; LUNG; METABOLISM; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

AMINES; AMMONIA; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LUNG; LUNG DISEASES; NITRIC OXIDE; NITROGEN; OXIDATION-REDUCTION; S-NITROSOTHIOLS;

EID: 84922777261     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021113-170352     Document Type: Article

References (151)

1. Joyce CJ, Williams AB. 1999. Kinetics of absorption atelectasis during anesthesia: amathematical model. J. Appl. Physiol. 86:1116-25
2. Schreiber F, Stief P, Gieseke A, Heisterkamp IM, Verstraete W, et al. 2010. Denitrification in human dental plaque. BMC Biol. 8:24
3. Mitsui T, Kato N, Kondo T. 2000. Estimation of nitrate metabolism in intestinal tract by measuring breath nitrous oxide concentration in Chinese and Japanese. Dig. Dis. Sci. 45:1002-5
4. Gaston B, Ratjen F, Vaughan JW,Malhotra NR, Canady RG, et al. 2002. Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. Am. J. Respir. Crit. CareMed. 165:387-90
5. Marozkina NV, Gaston B. 2011. Nitrogen balance in the ecosystem of the cystic fibrosis lung. Am. J. Respir. Crit. Care Med. 183:1290-92
6. Quinton PM. 2010. Role of epithelial HCO3-transport in mucin secretion: lessons from cystic fibrosis. Am. J. Physiol. Cell Physiol. 299:C1222-33
7. Pezzulo AA, Tang XX, HoeggerMJ, AlaiwaMH, Ramachandran S, et al. 2012. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487:109-13
8. Hunt JF, Erwin E, Palmer L, Vaughan J, Malhotra N, et al. 2002. Expression and activity of pHregulatory glutaminase in the human airway epithelium. Am. J. Respir. Crit. CareMed. 165:101-7
9. Ngamtrakulpanit L, Yu Y, Adjei A, Amoah G, Gaston B, Hunt J. 2010. Identification of intrinsic airway acidification in pulmonary tuberculosis. Glob. J. Health Sci. 2:106-10
10. Kostikas K, Papatheodorou G, GanasK, Psathakis K, Panagou P, Loukides S. 2002. pH in expired breath condensate of patients with inflammatory airway diseases. Am. J. Respir. Crit. CareMed. 165:1364-70
11. Carraro S, Doherty J, Zaman K, Gainov I, Turner R, et al. 2006. S-Nitrosothiols regulate cell-surface pH buffering by airway epithelial cells during the human immune response to rhinovirus. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L827-32
12. Hattori Y, Campbell EB, Gross SS. 1994. Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle. Role in the regeneration or arginine for nitric oxide synthesis. J. Biol. Chem. 269:9405-8
13. Engelen MP, Com G, Luiking YC, Deutz NE. 2013. Stimulated nitric oxide production and arginine deficiency in children with cystic fibrosis with nutritional failure. J. Pediatr. 163:369-75.e1
14. Grasemann H, Pencharz PB. 2013. Arginine metabolism in patients with cystic fibrosis. J. Pediatr. 163:317-19
15. DeMaster EG, Raij L, Archer SL, Weir EK. 1989. Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-Arginine to nitric oxide. Biochem. Biophys. Res. Commun. 163:527-33
16. Jensen DE, Belka GK, Du Bois GC. 1998. S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. Biochem. J. 331(Part 2):659-68
17. LiuL,Hausladen A, Zeng M, QueL,Heitman J, Stamler JS. 2001. Ametabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410:490-94
18. Leaf CD, Wishnok JS, Tannenbaum SR. 1989. L-Arginine is a precursor for nitrate biosynthesis in humans. Biochem. Biophys. Res. Commun. 163:1032-37
19. Hibbs JB Jr, Vavrin Z, Taintor RR. 1987. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550-65
20. Bredt DS, Snyder SH. 1990. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87:682-85
21. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, et al. 1993. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization.Am. J. Respir. Cell Mol. Biol. 9:371-77
22. Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, et al. 1994. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl. Acad. Sci. USA 91:10089-93
23. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. 1995. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl. Acad. Sci. USA 92:7809-13
24. Vodovotz Y, Russell D, Xie QW, Bogdan C, Nathan C. 1995. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J. Immunol. 154:2914-25
25. Fukuto JM, Bianco CL, Chavez TA. 2009. Nitroxyl (HNO) signaling. Free Radic. Biol.Med. 47:1318-24
26. Tsukahara H, Ishida T, Mayumi M. 1999. Gas-phase oxidation of nitric oxide: chemical kinetics and rate constant. Nitric Oxide 3:191-98
27. Liu X, Miller MJ, Joshi MS, Thomas DD, Lancaster JR Jr. 1998. Accelerated reaction of nitric oxide withO2 within the hydrophobic interior of biological membranes. Proc. Natl. Acad. Sci. USA 95:2175-79
28. Fernhoff NB, Derbyshire ER, Underbakke ES, Marletta MA. 2012. Heme-Assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide. J. Biol. Chem. 287:43053-62
29. Katsuki S, ArnoldW,MittalC,Murad F. 1977. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cycl. Nucleotide Res. 3:23-35
30. Gaston B, Drazen JM, Jansen A, Sugarbaker DA, Loscalzo J, et al. 1994. Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J. Pharmacol. Exp. Ther. 268:978-84
31. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, et al. 1993. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. USA 90:10957-61
32. PerkinsWJ, Pabelick C, Warner DO, JonesKA. 1998. cGMP-independent mechanism of airway smooth muscle relaxation induced by S-nitrosoglutathione. Am. J. Physiol. Cell Physiol. 275:C468-74
33. Jansen A, Drazen J, Osborne JA, Brown R, Loscalzo J, Stamler JS. 1992. The relaxant properties in guinea pig airways of S-nitrosothiols. J. Pharmacol. Exp. Ther. 261:154-60
34. Lilly CM, Stamler JS, Gaston B, Meckel C, Loscalzo J, Drazen JM. 1993. Modulation of vasoactive intestinal peptide pulmonary relaxation by NO in tracheally superfused guinea pig lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 265:L410-15
35. Bannenberg G, Xue J, Engman L, Cotgreave I, Moldeus P, Ryrfeldt A. 1995. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung. J. Pharmacol. Exp. Ther. 272:1238-45
36. Gaston B, Drazen JM, Loscalzo J, Stamler JS. 1994. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149:538-51
37. Snyder AH, McPherson ME, Hunt JF, Johnson M, Stamler JS, Gaston B. 2002. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am. J. Respir. Crit. Care Med. 165:922-26
38. Moya MP, Gow AJ, McMahon TJ, Toone EJ, Cheifetz IM, et al. 2001. S-Nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proc. Natl. Acad. Sci. USA 98:5792-97
39. Estevez AG, Jordan J. 2002. Nitric oxide and superoxide, a deadly cocktail. Ann. N. Y. Acad. Sci. 962:207-11
40. Nathan CF, Hibbs JB Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70
41. BroilletMC, Firestein S. 1996. Direct activation of the olfactory cyclic nucleotide-gated channel through modification of sulfhydryl groups by NO compounds. Neuron 16:377-85
42. Jeffers A, Xu X, Huang KT, Cho M, Hogg N, et al. 2005. Hemoglobin mediated nitrite activation of soluble guanylyl cyclase. Comp. Biochem. Physiol. A 142:130-35
43. Hopmann KH, Cardey B, Gladwin MT, Kim-Shapiro DB, Ghosh A. 2011. Hemoglobin as a nitrite anhydrase: modeling methemoglobin-mediated N2O3 formation. Chemistry 17:6348-58
44. Straub AC, Lohman AW, Billaud M, Johnstone SR, Dwyer ST, et al. 2012. Endothelial cell expression of haemoglobin αregulates nitric oxide signalling. Nature 491:473-77
45. Angelo M, Singel DJ, Stamler JS. 2006. An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc. Natl. Acad. Sci. USA 103:8366-71
46. Herold S, Rock G. 2005. Mechanistic studies of S-nitrosothiol formation by NO∗/O2 and by NO∗/methemoglobin. Arch. Biochem. Biophys. 436:386-96
47. Bunn HF, Nathan DG, Dover GJ, Hebbel RP, Platt OS, et al. 2010. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 116:687-92
48. Hebbel RP. 2011. Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-basedmedicine. Am. J.Hematol. 86:123-54
49. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. 1991. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun. 181:852-57
50. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. 2004. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 84:731-65
51. Stamler JS, Singel DJ, Loscalzo J. 1992. Biochemistry of nitric oxide and its redox-Activated forms. Science 258:1898-902
52. Foster MW, Hess DT, Stamler JS. 2009. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol. Med. 15:391-404
53. Gow AJ, Chen Q, Hess DT, Day BJ, Ischiropoulos H, Stamler JS. 2002. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J. Biol. Chem. 277:9637-40
54. Paige JS, Xu G, Stancevic B, Jaffrey SR. 2008. Nitrosothiol reactivity profiling identifies S-nitrosylated proteins with unexpected stability. Chem. Biol. 15:1307-16
55. Marozkina NV, Gaston B. 2012. S-Nitrosylation signaling regulates cellular protein interactions. Biochim. Biophys. Acta 1820:722-29
56. Zhang H, Xu Y, Joseph J, Kalyanaraman B. 2005. Intramolecular electron transfer between tyrosyl radical and cysteine residue inhibits tyrosine nitration and induces thiyl radical formation in model peptides treated with myeloperoxidase, H2O2, and NO2-: EPR SPIN trapping studies. J. Biol. Chem. 280:40684-98
57. Mannick JB, Schonhoff C, Papeta N, Ghafourifar P, Szibor M, et al. 2001. S-Nitrosylation of mitochondrial caspases. J. Cell Biol. 154:1111-16
58. Abrams AJ, Farooq A, Wang G. 2011. S-Nitrosylation of ApoE in Alzheimer's disease. Biochemistry 50:3405-7
59. Smith BC, Fernhoff NB,Marletta MA. 2012. Mechanism and kinetics of inducible nitric oxide synthase auto-S-nitrosation and inactivation. Biochemistry 51:1028-40
60. Schmidt HH, Hofmann H, Schindler U, Shutenko ZS, Cunningham DD, Feelisch M. 1996. No •NO from NO synthase. Proc. Natl. Acad. Sci. USA 93:14492-97
61. Kim SF, Huri DA, Snyder SH. 2005. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310:1966-70
62. Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, et al. 2007. Regulation of β-Adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase2Cell 129:511-22
63. Gonzalez DR, Treuer A, Sun QA, Stamler JS, Hare JM. 2009. S-Nitrosylation of cardiac ion channels. J. Cardiovasc. Pharmacol. 54:188-95
64. Rosenfeld RJ, Bonaventura J, Szymczyna BR, MacCoss MJ, Arvai AS, et al. 2010. Nitric-oxide synthase forms N-NO-pterin and S-NO-cys: implications for activity, allostery, and regulation. J. Biol. Chem. 285:31581-89
65. Ozawa K,Whalen EJ, Nelson CD,Mu Y, Hess DT, et al. 2008. S-Nitrosylation of β-Arrestin regulates β-Adrenergic receptor trafficking. Mol. Cell 31:395-405
66. Stamler JS, Toone EJ, Lipton SA, Sucher NJ. 1997. (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18:691-96
67. Perez-Mato I, Castro C, Ruiz FA, Corrales FJ, Mato JM. 1999. Methionine adenosyltransferase Snitrosylation is regulated by the basic and acidic amino acids surrounding the target thiol. J. Biol. Chem. 274:17075-79
68. Matsushita K, Morrell CN, Cambien B, Yang SX, Yamakuchi M, et al. 2003. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 115:139-50
69. Gaston B, Singel D, Doctor A, Stamler JS. 2006. S-Nitrosothiol signaling in respiratory biology. Am. J. Respir. Crit. Care Med. 173:1186-93
70. Marozkina NV, Wei C, Yemen S, Wallrabe H, Nagji AS, et al. 2012. S-Nitrosoglutathione reductase in human lung cancer. Am. J. Respir. Cell Mol. Biol. 46:63-70
71. Inoue K, Akaike T, Miyamoto Y, Okamoto T, Sawa T, et al. 1999. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J. Biol. Chem. 274:27069-75
72. Fang K, Johns R, Macdonald T, Kinter M, Gaston B. 2000. S-Nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L716-21
73. Benhar M, Forrester MT, Hess DT, Stamler JS. 2008. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 320:1050-54
74. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, Dimmeler S. 2002. Redox regulatory and anti-Apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine69Nat. Cell Biol. 4:743-49
75. Bateman RL, Rauh D, Tavshanjian B, Shokat KM. 2008. Human carbonyl reductase 1 is an Snitrosoglutathione reductase. J. Biol. Chem. 283:35756-62
76. Trujillo M, Alvarez MN, Peluffo G, Freeman BA, Radi R. 1998. Xanthine oxidase-mediated decomposition of S-nitrosothiols. J. Biol. Chem. 273:7828-34
77. Johnson MA, Macdonald TL, Mannick JB, Conaway MR, Gaston B. 2001. Accelerated S-nitrosothiol breakdown by amyotrophic lateral sclerosis mutant copper,zinc-superoxide dismutase. J. Biol. Chem. 276:39872-78
78. Ramachandran N, Root P, Jiang XM, Hogg PJ, Mutus B. 2001. Mechanism of transfer of NO from extracellular S-nitrosothiols into the cytosol by cell-surface protein disulfide isomerase. Proc. Natl. Acad. Sci. USA 98:9539-44
79. Kornberg MD, Sen N, Hara MR, Juluri KR, Nguyen JV, et al. 2010. GAPDH mediates nitrosylation of nuclear proteins. Nat. Cell Biol. 12:1094-100
80. Gaston B, Stamler JS. 1997. Nitrogen oxides and lung function. In The Lung: Scientific Foundations, ed. JWest, R Crystal, EWeibel, P Barnes, pp. 239-53. Philadelphia: Lippincott-Raven
81. Jaffrey SR. 2005. Detection and characterization of protein nitrosothiols. Methods Enzymol. 396:105-18
82. Hogg N, Singh RJ, Konorev E, Joseph J, Kalyanaraman B. 1997. S-Nitrosoglutathione as a substrate for γ-glutamyl transpeptidase. Biochem. J. 323(Part 2):477-81
83. Holder AA, Marshall SC, Wang PG, Kwak CH. 2003. The mechanism of the decomposition of a bronchodilator, S-nitroso-N-Acetyl-D,L-penicillamine (SNAP), by a bronchoconstrictor, aqueous sulfite: detection of the N-nitrosohydroxylamine-N-sulfonate ion. Bull. Korean Chem. Soc. 3:350-56
84. Doctor A, Platt R, SheramML, Eischeid A, McMahonT, et al. 2005. Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients. Proc. Natl. Acad. Sci. USA 102:5709-14
85. Pawloski JR, Hess DT, Stamler JS. 2001. Export by red blood cells of nitric oxide bioactivity. Nature 409:622-26
86. Zhang Y, Hogg N. 2004. The mechanism of transmembrane S-nitrosothiol transport. Proc. Natl. Acad. Sci. USA 101:7891-96
87. Lipton AJ, Johnson MA, Macdonald T, Lieberman MW, Gozal D, Gaston B. 2001. S-Nitrosothiols signal the ventilatory response to hypoxia. Nature 413:171-74
88. Zaman K, Hanigan MH, Smith A, Vaughan J, Macdonald T, et al. 2006. Endogenous Snitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 34:387-93
89. Marshall HE, Hess DT, Stamler JS. 2004. S-Nitrosylation: physiological regulation of NF-κB. Proc. Natl. Acad. Sci. USA 101:8841-42
90. Reynaert NL, Ckless K, Korn SH, Vos N, Guala AS, et al. 2004. Nitric oxide represses inhibitory κB kinase through S-nitrosylation. Proc. Natl. Acad. Sci. USA 101:8945-50
91. Zaman K, Palmer LA, Doctor A,Hunt JF, Gaston B. 2004. Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1. Biochem. J. 380:67-74
92. Hara MR, Snyder SH. 2006. Nitric oxide-GAPDH-Siah: a novel cell death cascade. Cell. Mol. Neurobiol. 26:527-38
93. Marozkina NV, Yemen S, Borowitz M, Liu L, Plapp M, et al. 2010. Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy. Proc. Natl. Acad. Sci. USA 107:11393-98
94. Palmer LA,Doctor A, Chhabra P, SheramML, Laubach VE, et al. 2007. S-Nitrosothiols signal hypoxiamimetic vascular pathology. J. Clin. Investig. 117:2592-601
95. Nott A, Watson PM, Robinson JD, Crepaldi L, Riccio A. 2008. S-Nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 455:411-15
96. Joksovic PM, Doctor A, Gaston B, Todorovic SM. 2007. Functional regulation of T-type calcium channels by S-nitrosothiols in the rat thalamus. J. Neurophysiol. 97:2712-21
97. Colasanti M, Persichini T, Venturini G, Ascenzi P. 1999. S-Nitrosylation of viral proteins: molecular bases for antiviral effect of nitric oxide. IUBMB Life 48:25-31
98. Mannick JB, Hausladen A, Liu L, Hess DT, Zeng M, et al. 1999. Fas-induced caspase denitrosylation. Science 284:651-54
99. Jain L, Chen XJ, Brown LA, Eaton DC. 1998. Nitric oxide inhibits lung sodium transport through a cGMP-mediated inhibition of epithelial cation channels. Am. J. Physiol. Lung Cell. Mol. Physiol. 274:L475-84
100. Kamosinska B, Radomski MW, Duszyk M, Radomski A, Man SF. 1997. Nitric oxide activates chloride currents in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 272:L1098-104
101. Duta V, Duta F, Puttagunta L, Befus AD, Duszyk M. 2006. Regulation of basolateral Cl-channels in airway epithelial cells: the role of nitric oxide. J. Membr. Biol. 213:165-74
102. Howard M, Fischer H, Roux J, Santos BC, Gullans SR, et al. 2003. Mammalian osmolytes and Snitrosoglutathione promote -F508 cystic fibrosis transmembrane conductance regulator (CFTR) protein maturation and function. J. Biol. Chem. 278:35159-67
103. Zaman K, Carraro S, Doherty J, Henderson EM, Lendermon E, et al. 2006. S-Nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells. Mol. Pharmacol. 70:1435-42
104. Atochina-Vasserman EN, Gow AJ, Abramova H, Guo CJ, Tomer Y, et al. 2009. Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by Snitrosylation. J. Immunol. 182:2277-87
105. Gaston B, Sears S,Woods J, Hunt J, Ponaman M, et al. 1998. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 351:1317-19
106. Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, et al. 2001. Gender differences in pharmacokinetics of alcohol. Alcohol. Clin. Exp. Res. 25:502-7
107. Brown-Steinke K, deRonde K, Yemen S, Palmer LA. 2010. Gender differences in S-nitrosoglutathione reductase activity in the lung. PLOS ONE 5:e14007
108. Que LG, Liu L, Yan Y, Whitehead GS, Gavett SH, et al. 2005. Protection from experimental asthma by an endogenous bronchodilator. Science 308:1618-21
109. Moore PE, Ryckman KK, Williams SM, Patel N, Summar ML, Sheller JR. 2009. Genetic variants in GSNOR and ADRB2 influence response to albuterol in African-American children with severe asthma. Pediatr. Pulmonol. 44:649-54
110. Liu L, Yan Y, Zeng M, Zhang J, Hanes MA, et al. 2004. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 116:617-28
111. Evangelista AM, Rao VS, Filo AR, Marozkina NV, Doctor A, et al. 2010. Direct regulation of striated muscle myosins by nitric oxide and endogenous nitrosothiols. PLOS ONE 5:e11209
112. Davisson RL, Travis MD, Bates JN, Lewis SJ. 1996. Hemodynamic effects of L-And D-S-nitrosocysteine in the rat. Stereoselective S-nitrosothiol recognition sites. Circ. Res. 79:256-62
113. Pabelick CM, Warner DO, Perkins WJ, Jones KA. 2000. S-Nitrosoglutathione-induced decrease in calcium sensitivity of airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:L521-27
114. Bhandari V, Choo-Wing R, Chapoval SP, Lee CG, Tang C, et al. 2006. Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung. Proc. Natl. Acad. Sci. USA 103:11021-26
115. Moya MP, Gow AJ, Califf RM, Goldberg RN, Stamler JS. 2002. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn. Lancet 360:141-43
116. Gaston B, May WJ, Sullivan S, Yemen S, Marozkina NV, et al. 2014. Essential role of hemoglobin β-93-cysteine in posthypoxia facilitation of breathing in conscious mice. J. Appl. Physiol. 116:1290-99
117. Reynolds JD, Bennett KM, Cina AJ, Diesen DL, Henderson MB, et al. 2013. S-Nitrosylation therapy to improve oxygen delivery of banked blood. Proc. Natl. Acad. Sci. USA 110:11529-34
118. Li D, Shirakami G, Zhan X, Johns RA. 2000. Regulation of ciliary beat frequency by the nitric oxide-cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 23:175-81
119. Fischer A, Mundel P, Mayer B, Preissler U, Philippin B, Kummer W. 1993. Nitric oxide synthase in guinea pig lower airway innervation. Neurosci. Lett. 149:157-60
120. Melamed Y, Shupak A, Bitterman H. 1992. Medical problems associated with underwater diving. N. Engl. J. Med. 326:30-35
121. Rabin HR, Surette MG. 2012. The cystic fibrosis airway microbiome. Curr. Opin. Pulm. Med. 18:622-27
122. Elsayed NM. 1994. Toxicity of nitrogen dioxide: an introduction. Toxicology 89:161-74
123. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. 1994. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Investig. 94:2407-13
124. Afshari A, Brok J,Moller AM, Wetterslev J. 2010. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst. Rev. 2010:CD002787
125. Wang D, Li MH, Hsu K, Shen CY, Chen HI, Lin YC. 1992. Air embolism-induced lung injury in isolated rat lungs. J. Appl. Physiol. 72:1235-42
126. Marshall HE, Potts EN, Kelleher ZT, Stamler JS, Foster WM, Auten RL. 2009. Protection from lipopolysaccharide-induced lung injury by augmentation of airway S-nitrosothiols. Am. J. Respir. Crit. Care Med. 180:11-18
127. Lim KH, Ancrile BB, Kashatus DF, Counter CM. 2008. Tumour maintenance is mediated by eNOS. Nature 452:646-49
128. Wei W, Li B, Hanes MA, Kakar S, Chen X, Liu L. 2010. S-Nitrosylation from GSNOR deficiency impairs DNA repair and promotes hepatocarcinogenesis. Sci. Transl. Med. 2:19ra3
129. Dweik RA, Comhair SA, Gaston B, Thunnissen FB, Farver C, et al. 2001. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc. Natl. Acad. Sci. USA 98:2622-27
130. Guo FH, Uetani K, Haque SJ, Williams BR, Dweik RA, et al. 1997. Interferon γ and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J. Clin. Investig. 100:829-38
131. Eiserich JP, HristovaM,Cross CE, Jones AD, Freeman BA, et al. 1998. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393-97
132. Alving K, WeitzbergE, Lundberg JM. 1993. Increased amount of nitric oxide in exhaled air of asthmatics. Eur. Respir. J. 6:1368-70
133. Gaston B, Massaro A, Drazen J, Chee CBE, Wohl MEB, Stamler JS. 1994. Expired nitric oxide concentrations are elevated in patients with asthma. In The Biology of Nitric Oxide, Vol. 3: Physiological and Clinical Aspects, ed. S Moncada, pp. 497-500. London: Portland Press Proc.
134. Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, et al. 2003. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J. 17:1298-300
135. De Sanctis GT, MacLean JA, Hamada K, Mehta S, Scott JA, et al. 1999. Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J. Exp. Med. 189:1621-30
136. Petsky HL,Cates CJ, Lasserson TJ, Li AM, Turner C, et al. 2012. A systematic review andmeta-Analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 67:199-208
137. Liu L, Urban P, Hunt JF,Wilkinson P, Laning K, Gaston B. 2010. Changes in exhaled nitric oxide and breath pH during fluticasone wean in asthma. Respiration 79:193-99
138. Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, et al. 2010. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am. J. Respir. Crit. Care Med. 181:1033-41
139. Que LG, Yang Z, Stamler JS, Lugogo NL, Kraft M. 2009. S-Nitrosoglutathione reductase: an important regulator in human asthma. Am. J. Respir. Crit. CareMed. 180:226-31
140. Liu L, Teague WG, Erzurum S, Fitzpatrick A, Mantri S, et al. 2011. Determinants of exhaled breath condensate pH in a large population with asthma. Chest 139:328-36
141. Gaston B, Kelly R, Urban P, Liu L, Henderson EM, et al. 2006. Buffering airway acid decreases exhaled nitric oxide in asthma. J. Allergy Clin. Immunol. 118:817-22
142. Yoon SS, CoakleyR,LauGW,Lymar SV,Gaston B, et al. 2006. Anaerobic killing ofmucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Investig. 116:436-46
143. Grasemann H, Gaston B, Fang K, Paul K, Ratjen F. 1999. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J. Pediatr. 135:770-72
144. Grasemann H, Al-Saleh S, Scott JA, Shehnaz D, Mehl A, et al. 2011. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis.Am. J. Respir. Crit. CareMed. 183:1363-68
145. PiacentiniGL, Bodini A, Peroni D, Rigotti E, Pigozzi R, et al. 2008. Nasal nitric oxide for early diagnosis of primary ciliary dyskinesia: practical issues in children. Respir. Med. 102:541-47
146. Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, et al. 2004. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am. J. Respir. Crit. CareMed. 169:459-67
147. Balfour-Lynn IM, Laverty A, Dinwiddie R. 1996. Reduced upper airway nitric oxide in cystic fibrosis. Arch. Dis. Child. 75:319-22
148. Nakano H, Ide H, Imada M, Osanai S, Takahashi T, et al. 2000. Reduced nasal nitric oxide in diffuse panbronchiolitis. Am. J. Respir. Crit. Care Med. 162:2218-20
149. Degano B, Valmary S, Serrano E, Brousset P, Arnal JF. 2011. Expression of nitric oxide synthases in primary ciliary dyskinesia. Hum. Pathol. 42:1855-61
150. McMahon TJ, Moon RE, Luchsinger BP, Carraway MS, Stone AE, et al. 2002. Nitric oxide in the human respiraotry cycle. Nat. Med. 8:711-17
151. McMahon TJ, Ahearn GS, Moya MP, Gow AJ, Huang YC, et al. 2005. A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension. Proc. Natl. Acad. Sci. USA 102:14801-6